Ben A. Hitt

Correlogic Systems, Inc. has pioneered the use of pattern recognition technologies for the development of proteomic, metabolomic and genomic based clinical prognostic and clinical diagnostic tests. The company has applied its proprietary software and sample preparation technologies to a wide range of high throughput bioassay platforms, including mass spectrometry, nuclear magnetic resonance spectrometry, nucleic acid arrays, and immunoassays. Correlogic's technologies have a wide range of applications for the creation of disease classification models, biomarker discovery, and new drug discovery processes. Correlogic's research, demonstrating results in cancer and non-cancer disease research, drug discovery, drug response monitoring, bio-security and other applications has been published in 13 peer-reviewed journals. Correlogic is also a clinical laboratory regulated under the Clinical Laboratory Improvement Amendments of 1988, designated to perform high complexity testing. Correlogic has entered into agreements to provide an ovarian cancer testing service in cooperation with the nation's two premier diagnostic laboratories, Quest Diagnostics and Laboratory Corporation of America.

Part of Emerson Electric Co., NeuralWare, Inc. is a supplier and developer of neural network software. The company is based in Pittsburgh, PA. NeuralWare was acquired by AspenTech Corp., part of Emerson Electric Co. from May 17, 2022 on September 04, 1997.

Raytheon Systems Ltd. designs, develops, and manufactures advanced electronic products and systems. Its aerospace electronics offerings include air traffic control systems, command and control systems, navigation systems, and identification friend or foe systems. The company also makes power and control products such as motor drives, power supplies, circuit boards, and semiconductors. It provides aircraft repair, maintenance and modification services, logistics support, and project management services. The company is headquartered in Harlow, the United Kingdom.